- Patent Title: Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
-
Application No.: US15675399Application Date: 2017-08-11
-
Publication No.: US10172957B2Publication Date: 2019-01-08
- Inventor: James D. McChesney , John T. Henri , Sylesh Kumar Venkataraman , Mahesh Kumar Gundluru
- Applicant: Arbor Therapeutics, LLC
- Applicant Address: US MS Etta
- Assignee: Veiled Therapeutics, LLC
- Current Assignee: Veiled Therapeutics, LLC
- Current Assignee Address: US MS Etta
- Agency: Hamilton Desanctis & Cha, LLP
- Agent Sam L. Nguyen
- Main IPC: A61K47/54
- IPC: A61K47/54 ; C07D305/14 ; C07D317/24 ; C07D407/12 ; C07D487/04 ; C07D491/14 ; C07D493/06 ; C07D493/08 ; C07D519/00 ; A61K31/337 ; A61K31/357
Abstract:
The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of chemotherapy associated with the administration of a cancer chemotherapeutic agent to a patient in need thereof.
Public/Granted literature
- US20180161439A1 Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents Public/Granted day:2018-06-14
Information query
